カテゴリー： 世界, 医療/バイオ, LP Information

世界の医薬品用脂質市場予測 2023年-2029年

【英語タイトル】Global Pharmaceuticals Lipids Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC00099）・商品コード：LP23DC00099
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：92
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の医薬品用脂質市場」は、過去の販売実績から2022年の世界の医薬品用脂質の総販売量を検討し、2023年から2029年の予測される医薬品用脂質の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の医薬品用脂質の市場規模を掲載し、XXX百万米ドル規模の世界の医薬品用脂質市場の詳細な分析を提供します。本インサイトレポートは、世界の医薬品用脂質業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の医薬品用脂質市場における各社の独自のポジションをより深く理解するために、医薬品用脂質製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の医薬品用脂質市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。医薬品用脂質の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。医薬品用脂質の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。医薬品用脂質のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

医薬品用脂質の世界主要メーカーとしては、CordenPharma International、 Cerbios-Pharma、 Avanti Polar Lipids、 VAV Life Sciences Merck、 Sancilio & Company、 Cayman Chemical、 Esperion Therapeuticsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の医薬品用脂質市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では医薬品用脂質市場をセグメンテーションし、種類別 (中性脂肪、リン脂質、スフィンゴ脂質、コレステロール、脂肪酸)、用途別 (病院、ドラッグストア、小売店、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：中性脂肪、リン脂質、スフィンゴ脂質、コレステロール、脂肪酸

・用途別区分：病院、ドラッグストア、小売店、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の医薬品用脂質市場の10年間の市場状況・展望は？
・世界および地域別に見た医薬品用脂質市場成長の要因は何か？
・医薬品用脂質の市場機会はエンドマーケットの規模によってどのように変化するのか？
・医薬品用脂質のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：医薬品用脂質の年間販売量2018-2029、地域別現状・将来分析
・医薬品用脂質の種類別セグメント：中性脂肪、リン脂質、スフィンゴ脂質、コレステロール、脂肪酸
・医薬品用脂質の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・医薬品用脂質の用途別セグメント：病院、ドラッグストア、小売店、その他
・医薬品用脂質の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の医薬品用脂質市場
・企業別のグローバル医薬品用脂質市場データ：2018-2023年の年間販売量、市場シェア
・企業別の医薬品用脂質の年間売上：2018-2023年の売上、市場シェア
・企業別の医薬品用脂質販売価格
・主要企業の医薬品用脂質生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

医薬品用脂質の地域別レビュー
・地域別の医薬品用脂質市場規模2018-2023：年間販売量、売上
・主要国別の医薬品用脂質市場規模2018-2023：年間販売量、売上
・南北アメリカの医薬品用脂質販売の成長
・アジア太平洋の医薬品用脂質販売の成長
・ヨーロッパの医薬品用脂質販売の成長
・中東・アフリカの医薬品用脂質販売の成長

南北アメリカ市場
・南北アメリカの国別の医薬品用脂質販売量、売上（2018-2023）
・南北アメリカの医薬品用脂質の種類別販売量
・南北アメリカの医薬品用脂質の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の医薬品用脂質販売量、売上（2018-2023）
・アジア太平洋の医薬品用脂質の種類別販売量
・アジア太平洋の医薬品用脂質の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の医薬品用脂質販売量、売上（2018-2023）
・ヨーロッパの医薬品用脂質の種類別販売量
・ヨーロッパの医薬品用脂質の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の医薬品用脂質販売量、売上（2018-2023）
・中東・アフリカの医薬品用脂質の種類別販売量
・中東・アフリカの医薬品用脂質の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・医薬品用脂質の製造コスト構造分析
・医薬品用脂質の製造プロセス分析
・医薬品用脂質の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・医薬品用脂質の主要なグローバル販売業者
・医薬品用脂質の主要なグローバル顧客

地域別の医薬品用脂質市場予測レビュー
・地域別の医薬品用脂質市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・医薬品用脂質の種類別市場規模予測
・医薬品用脂質の用途別市場規模予測

主要企業分析
CordenPharma International、 Cerbios-Pharma、 Avanti Polar Lipids、 VAV Life Sciences Merck、 Sancilio & Company、 Cayman Chemical、 Esperion Therapeutics
・企業情報
・医薬品用脂質製品
・医薬品用脂質販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Pharmaceuticals Lipids market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceuticals Lipids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceuticals Lipids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceuticals Lipids is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceuticals Lipids players cover CordenPharma International, Cerbios-Pharma, Avanti Polar Lipids, VAV Life Sciences Merck, Sancilio & Company, Cayman Chemical and Esperion Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Lipids are eclectic group of organic compounds which generally present in microorganisms, animals, as well as plants. They incorporate waxes, fats, sterols, and fat-soluble nutrients which are natural molecules. They have most of their use as drug excipients for the creation of a drug. They have short toxicity and can accomplish a huge combination of action that leads to better drug delivery, indirectly strengthening the market growth.
LPI (LP Information)’ newest research report, the “Pharmaceuticals Lipids Industry Forecast” looks at past sales and reviews total world Pharmaceuticals Lipids sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceuticals Lipids sales for 2023 through 2029. With Pharmaceuticals Lipids sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceuticals Lipids industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceuticals Lipids landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceuticals Lipids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceuticals Lipids market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceuticals Lipids and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceuticals Lipids.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceuticals Lipids market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Triglycerides
Phospholipids
Sphingolipids
Cholesterol
Fatty Acids
Segmentation by application
Hospitals
Drug Stores
Retail Stores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
CordenPharma International
Cerbios-Pharma
Avanti Polar Lipids
VAV Life Sciences Merck
Sancilio & Company
Cayman Chemical
Esperion Therapeutics
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceuticals Lipids market?
What factors are driving Pharmaceuticals Lipids market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceuticals Lipids market opportunities vary by end market size?
How does Pharmaceuticals Lipids break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceuticals Lipids Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pharmaceuticals Lipids by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pharmaceuticals Lipids by Country/Region, 2018, 2022 & 2029
2.2 Pharmaceuticals Lipids Segment by Type
2.2.1 Triglycerides
2.2.2 Phospholipids
2.2.3 Sphingolipids
2.2.4 Cholesterol
2.2.5 Fatty Acids
2.3 Pharmaceuticals Lipids Sales by Type
2.3.1 Global Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
2.3.2 Global Pharmaceuticals Lipids Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pharmaceuticals Lipids Sale Price by Type (2018-2023)
2.4 Pharmaceuticals Lipids Segment by Application
2.4.1 Hospitals
2.4.2 Drug Stores
2.4.3 Retail Stores
2.4.4 Others
2.5 Pharmaceuticals Lipids Sales by Application
2.5.1 Global Pharmaceuticals Lipids Sale Market Share by Application (2018-2023)
2.5.2 Global Pharmaceuticals Lipids Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pharmaceuticals Lipids Sale Price by Application (2018-2023)
3 Global Pharmaceuticals Lipids by Company
3.1 Global Pharmaceuticals Lipids Breakdown Data by Company
3.1.1 Global Pharmaceuticals Lipids Annual Sales by Company (2018-2023)
3.1.2 Global Pharmaceuticals Lipids Sales Market Share by Company (2018-2023)
3.2 Global Pharmaceuticals Lipids Annual Revenue by Company (2018-2023)
3.2.1 Global Pharmaceuticals Lipids Revenue by Company (2018-2023)
3.2.2 Global Pharmaceuticals Lipids Revenue Market Share by Company (2018-2023)
3.3 Global Pharmaceuticals Lipids Sale Price by Company
3.4 Key Manufacturers Pharmaceuticals Lipids Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceuticals Lipids Product Location Distribution
3.4.2 Players Pharmaceuticals Lipids Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceuticals Lipids by Geographic Region
4.1 World Historic Pharmaceuticals Lipids Market Size by Geographic Region (2018-2023)
4.1.1 Global Pharmaceuticals Lipids Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pharmaceuticals Lipids Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pharmaceuticals Lipids Market Size by Country/Region (2018-2023)
4.2.1 Global Pharmaceuticals Lipids Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pharmaceuticals Lipids Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pharmaceuticals Lipids Sales Growth
4.4 APAC Pharmaceuticals Lipids Sales Growth
4.5 Europe Pharmaceuticals Lipids Sales Growth
4.6 Middle East & Africa Pharmaceuticals Lipids Sales Growth
5 Americas
5.1 Americas Pharmaceuticals Lipids Sales by Country
5.1.1 Americas Pharmaceuticals Lipids Sales by Country (2018-2023)
5.1.2 Americas Pharmaceuticals Lipids Revenue by Country (2018-2023)
5.2 Americas Pharmaceuticals Lipids Sales by Type
5.3 Americas Pharmaceuticals Lipids Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceuticals Lipids Sales by Region
6.1.1 APAC Pharmaceuticals Lipids Sales by Region (2018-2023)
6.1.2 APAC Pharmaceuticals Lipids Revenue by Region (2018-2023)
6.2 APAC Pharmaceuticals Lipids Sales by Type
6.3 APAC Pharmaceuticals Lipids Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceuticals Lipids by Country
7.1.1 Europe Pharmaceuticals Lipids Sales by Country (2018-2023)
7.1.2 Europe Pharmaceuticals Lipids Revenue by Country (2018-2023)
7.2 Europe Pharmaceuticals Lipids Sales by Type
7.3 Europe Pharmaceuticals Lipids Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceuticals Lipids by Country
8.1.1 Middle East & Africa Pharmaceuticals Lipids Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pharmaceuticals Lipids Revenue by Country (2018-2023)
8.2 Middle East & Africa Pharmaceuticals Lipids Sales by Type
8.3 Middle East & Africa Pharmaceuticals Lipids Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceuticals Lipids
10.3 Manufacturing Process Analysis of Pharmaceuticals Lipids
10.4 Industry Chain Structure of Pharmaceuticals Lipids
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceuticals Lipids Distributors
11.3 Pharmaceuticals Lipids Customer
12 World Forecast Review for Pharmaceuticals Lipids by Geographic Region
12.1 Global Pharmaceuticals Lipids Market Size Forecast by Region
12.1.1 Global Pharmaceuticals Lipids Forecast by Region (2024-2029)
12.1.2 Global Pharmaceuticals Lipids Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceuticals Lipids Forecast by Type
12.7 Global Pharmaceuticals Lipids Forecast by Application
13 Key Players Analysis
13.1 CordenPharma International
13.1.1 CordenPharma International Company Information
13.1.2 CordenPharma International Pharmaceuticals Lipids Product Portfolios and Specifications
13.1.3 CordenPharma International Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CordenPharma International Main Business Overview
13.1.5 CordenPharma International Latest Developments
13.2 Cerbios-Pharma
13.2.1 Cerbios-Pharma Company Information
13.2.2 Cerbios-Pharma Pharmaceuticals Lipids Product Portfolios and Specifications
13.2.3 Cerbios-Pharma Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cerbios-Pharma Main Business Overview
13.2.5 Cerbios-Pharma Latest Developments
13.3 Avanti Polar Lipids
13.3.1 Avanti Polar Lipids Company Information
13.3.2 Avanti Polar Lipids Pharmaceuticals Lipids Product Portfolios and Specifications
13.3.3 Avanti Polar Lipids Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Avanti Polar Lipids Main Business Overview
13.3.5 Avanti Polar Lipids Latest Developments
13.4 VAV Life Sciences Merck
13.4.1 VAV Life Sciences Merck Company Information
13.4.2 VAV Life Sciences Merck Pharmaceuticals Lipids Product Portfolios and Specifications
13.4.3 VAV Life Sciences Merck Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 VAV Life Sciences Merck Main Business Overview
13.4.5 VAV Life Sciences Merck Latest Developments
13.5 Sancilio & Company
13.5.1 Sancilio & Company Company Information
13.5.2 Sancilio & Company Pharmaceuticals Lipids Product Portfolios and Specifications
13.5.3 Sancilio & Company Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sancilio & Company Main Business Overview
13.5.5 Sancilio & Company Latest Developments
13.6 Cayman Chemical
13.6.1 Cayman Chemical Company Information
13.6.2 Cayman Chemical Pharmaceuticals Lipids Product Portfolios and Specifications
13.6.3 Cayman Chemical Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cayman Chemical Main Business Overview
13.6.5 Cayman Chemical Latest Developments
13.7 Esperion Therapeutics
13.7.1 Esperion Therapeutics Company Information
13.7.2 Esperion Therapeutics Pharmaceuticals Lipids Product Portfolios and Specifications
13.7.3 Esperion Therapeutics Pharmaceuticals Lipids Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Esperion Therapeutics Main Business Overview
13.7.5 Esperion Therapeutics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Pharmaceuticals Lipids Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pharmaceuticals Lipids Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Triglycerides
Table 4. Major Players of Phospholipids
Table 5. Major Players of Sphingolipids
Table 6. Major Players of Cholesterol
Table 7. Major Players of Fatty Acids
Table 8. Global Pharmaceuticals Lipids Sales by Type (2018-2023) & (K Units)
Table 9. Global Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
Table 10. Global Pharmaceuticals Lipids Revenue by Type (2018-2023) & ($ million)
Table 11. Global Pharmaceuticals Lipids Revenue Market Share by Type (2018-2023)
Table 12. Global Pharmaceuticals Lipids Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Pharmaceuticals Lipids Sales by Application (2018-2023) & (K Units)
Table 14. Global Pharmaceuticals Lipids Sales Market Share by Application (2018-2023)
Table 15. Global Pharmaceuticals Lipids Revenue by Application (2018-2023)
Table 16. Global Pharmaceuticals Lipids Revenue Market Share by Application (2018-2023)
Table 17. Global Pharmaceuticals Lipids Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Pharmaceuticals Lipids Sales by Company (2018-2023) & (K Units)
Table 19. Global Pharmaceuticals Lipids Sales Market Share by Company (2018-2023)
Table 20. Global Pharmaceuticals Lipids Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Pharmaceuticals Lipids Revenue Market Share by Company (2018-2023)
Table 22. Global Pharmaceuticals Lipids Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Pharmaceuticals Lipids Producing Area Distribution and Sales Area
Table 24. Players Pharmaceuticals Lipids Products Offered
Table 25. Pharmaceuticals Lipids Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Pharmaceuticals Lipids Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Pharmaceuticals Lipids Sales Market Share Geographic Region (2018-2023)
Table 30. Global Pharmaceuticals Lipids Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Pharmaceuticals Lipids Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Pharmaceuticals Lipids Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Pharmaceuticals Lipids Sales Market Share by Country/Region (2018-2023)
Table 34. Global Pharmaceuticals Lipids Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Pharmaceuticals Lipids Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Pharmaceuticals Lipids Sales by Country (2018-2023) & (K Units)
Table 37. Americas Pharmaceuticals Lipids Sales Market Share by Country (2018-2023)
Table 38. Americas Pharmaceuticals Lipids Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Pharmaceuticals Lipids Revenue Market Share by Country (2018-2023)
Table 40. Americas Pharmaceuticals Lipids Sales by Type (2018-2023) & (K Units)
Table 41. Americas Pharmaceuticals Lipids Sales by Application (2018-2023) & (K Units)
Table 42. APAC Pharmaceuticals Lipids Sales by Region (2018-2023) & (K Units)
Table 43. APAC Pharmaceuticals Lipids Sales Market Share by Region (2018-2023)
Table 44. APAC Pharmaceuticals Lipids Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Pharmaceuticals Lipids Revenue Market Share by Region (2018-2023)
Table 46. APAC Pharmaceuticals Lipids Sales by Type (2018-2023) & (K Units)
Table 47. APAC Pharmaceuticals Lipids Sales by Application (2018-2023) & (K Units)
Table 48. Europe Pharmaceuticals Lipids Sales by Country (2018-2023) & (K Units)
Table 49. Europe Pharmaceuticals Lipids Sales Market Share by Country (2018-2023)
Table 50. Europe Pharmaceuticals Lipids Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Pharmaceuticals Lipids Revenue Market Share by Country (2018-2023)
Table 52. Europe Pharmaceuticals Lipids Sales by Type (2018-2023) & (K Units)
Table 53. Europe Pharmaceuticals Lipids Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Pharmaceuticals Lipids Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Pharmaceuticals Lipids Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pharmaceuticals Lipids Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Pharmaceuticals Lipids Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Pharmaceuticals Lipids Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Pharmaceuticals Lipids Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Pharmaceuticals Lipids
Table 61. Key Market Challenges & Risks of Pharmaceuticals Lipids
Table 62. Key Industry Trends of Pharmaceuticals Lipids
Table 63. Pharmaceuticals Lipids Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Pharmaceuticals Lipids Distributors List
Table 66. Pharmaceuticals Lipids Customer List
Table 67. Global Pharmaceuticals Lipids Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Pharmaceuticals Lipids Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Pharmaceuticals Lipids Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Pharmaceuticals Lipids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Pharmaceuticals Lipids Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Pharmaceuticals Lipids Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Pharmaceuticals Lipids Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Pharmaceuticals Lipids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Pharmaceuticals Lipids Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Pharmaceuticals Lipids Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Pharmaceuticals Lipids Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Pharmaceuticals Lipids Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Pharmaceuticals Lipids Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Pharmaceuticals Lipids Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CordenPharma International Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 82. CordenPharma International Pharmaceuticals Lipids Product Portfolios and Specifications
Table 83. CordenPharma International Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. CordenPharma International Main Business
Table 85. CordenPharma International Latest Developments
Table 86. Cerbios-Pharma Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 87. Cerbios-Pharma Pharmaceuticals Lipids Product Portfolios and Specifications
Table 88. Cerbios-Pharma Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Cerbios-Pharma Main Business
Table 90. Cerbios-Pharma Latest Developments
Table 91. Avanti Polar Lipids Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 92. Avanti Polar Lipids Pharmaceuticals Lipids Product Portfolios and Specifications
Table 93. Avanti Polar Lipids Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Avanti Polar Lipids Main Business
Table 95. Avanti Polar Lipids Latest Developments
Table 96. VAV Life Sciences Merck Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 97. VAV Life Sciences Merck Pharmaceuticals Lipids Product Portfolios and Specifications
Table 98. VAV Life Sciences Merck Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. VAV Life Sciences Merck Main Business
Table 100. VAV Life Sciences Merck Latest Developments
Table 101. Sancilio & Company Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 102. Sancilio & Company Pharmaceuticals Lipids Product Portfolios and Specifications
Table 103. Sancilio & Company Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Sancilio & Company Main Business
Table 105. Sancilio & Company Latest Developments
Table 106. Cayman Chemical Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 107. Cayman Chemical Pharmaceuticals Lipids Product Portfolios and Specifications
Table 108. Cayman Chemical Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Cayman Chemical Main Business
Table 110. Cayman Chemical Latest Developments
Table 111. Esperion Therapeutics Basic Information, Pharmaceuticals Lipids Manufacturing Base, Sales Area and Its Competitors
Table 112. Esperion Therapeutics Pharmaceuticals Lipids Product Portfolios and Specifications
Table 113. Esperion Therapeutics Pharmaceuticals Lipids Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Esperion Therapeutics Main Business
Table 115. Esperion Therapeutics Latest Developments
List of Figures
Figure 1. Picture of Pharmaceuticals Lipids
Figure 2. Pharmaceuticals Lipids Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceuticals Lipids Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pharmaceuticals Lipids Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pharmaceuticals Lipids Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Triglycerides
Figure 10. Product Picture of Phospholipids
Figure 11. Product Picture of Sphingolipids
Figure 12. Product Picture of Cholesterol
Figure 13. Product Picture of Fatty Acids
Figure 14. Global Pharmaceuticals Lipids Sales Market Share by Type in 2022
Figure 15. Global Pharmaceuticals Lipids Revenue Market Share by Type (2018-2023)
Figure 16. Pharmaceuticals Lipids Consumed in Hospitals
Figure 17. Global Pharmaceuticals Lipids Market: Hospitals (2018-2023) & (K Units)
Figure 18. Pharmaceuticals Lipids Consumed in Drug Stores
Figure 19. Global Pharmaceuticals Lipids Market: Drug Stores (2018-2023) & (K Units)
Figure 20. Pharmaceuticals Lipids Consumed in Retail Stores
Figure 21. Global Pharmaceuticals Lipids Market: Retail Stores (2018-2023) & (K Units)
Figure 22. Pharmaceuticals Lipids Consumed in Others
Figure 23. Global Pharmaceuticals Lipids Market: Others (2018-2023) & (K Units)
Figure 24. Global Pharmaceuticals Lipids Sales Market Share by Application (2022)
Figure 25. Global Pharmaceuticals Lipids Revenue Market Share by Application in 2022
Figure 26. Pharmaceuticals Lipids Sales Market by Company in 2022 (K Units)
Figure 27. Global Pharmaceuticals Lipids Sales Market Share by Company in 2022
Figure 28. Pharmaceuticals Lipids Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Pharmaceuticals Lipids Revenue Market Share by Company in 2022
Figure 30. Global Pharmaceuticals Lipids Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Pharmaceuticals Lipids Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Pharmaceuticals Lipids Sales 2018-2023 (K Units)
Figure 33. Americas Pharmaceuticals Lipids Revenue 2018-2023 ($ Millions)
Figure 34. APAC Pharmaceuticals Lipids Sales 2018-2023 (K Units)
Figure 35. APAC Pharmaceuticals Lipids Revenue 2018-2023 ($ Millions)
Figure 36. Europe Pharmaceuticals Lipids Sales 2018-2023 (K Units)
Figure 37. Europe Pharmaceuticals Lipids Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Pharmaceuticals Lipids Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Pharmaceuticals Lipids Revenue 2018-2023 ($ Millions)
Figure 40. Americas Pharmaceuticals Lipids Sales Market Share by Country in 2022
Figure 41. Americas Pharmaceuticals Lipids Revenue Market Share by Country in 2022
Figure 42. Americas Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
Figure 43. Americas Pharmaceuticals Lipids Sales Market Share by Application (2018-2023)
Figure 44. United States Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Pharmaceuticals Lipids Sales Market Share by Region in 2022
Figure 49. APAC Pharmaceuticals Lipids Revenue Market Share by Regions in 2022
Figure 50. APAC Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
Figure 51. APAC Pharmaceuticals Lipids Sales Market Share by Application (2018-2023)
Figure 52. China Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Pharmaceuticals Lipids Sales Market Share by Country in 2022
Figure 60. Europe Pharmaceuticals Lipids Revenue Market Share by Country in 2022
Figure 61. Europe Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
Figure 62. Europe Pharmaceuticals Lipids Sales Market Share by Application (2018-2023)
Figure 63. Germany Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Pharmaceuticals Lipids Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Pharmaceuticals Lipids Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Pharmaceuticals Lipids Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Pharmaceuticals Lipids Sales Market Share by Application (2018-2023)
Figure 72. Egypt Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Pharmaceuticals Lipids Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pharmaceuticals Lipids in 2022
Figure 78. Manufacturing Process Analysis of Pharmaceuticals Lipids
Figure 79. Industry Chain Structure of Pharmaceuticals Lipids
Figure 80. Channels of Distribution
Figure 81. Global Pharmaceuticals Lipids Sales Market Forecast by Region (2024-2029)
Figure 82. Global Pharmaceuticals Lipids Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Pharmaceuticals Lipids Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Pharmaceuticals Lipids Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Pharmaceuticals Lipids Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Pharmaceuticals Lipids Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の医薬品用脂質市場予測 2023年-2029年] (コード：LP23DC00099)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の医薬品用脂質市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品用再利用可能温度管理包装市場予測 2023年-2029年
  • 世界のカリウム競合拮抗薬市場予測 2023年-2029年
  • 世界のアルカリ化剤市場予測 2023年-2029年
  • 世界のネビボロール塩酸塩API市場予測 2023年-2029年
  • 世界のネビボロール塩酸塩API市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆